MEMPHIS, Tenn. (June 4, 2018) - Fred's, Inc. (NASDAQ: FRED) has closed the previously announced sale of certain assets of EntrustRx, its specialty pharmacy unit, to a subsidiary of CVS Health Corporation. The aggregate consideration paid was $40.0 million, plus an amount equal to the value of inventory of EntrustRx.

Commenting on the sale, Fred's Interim CEO Joe Anto said: 'We are pleased to conclude the sale of EntrustRx, an important step in our plans to monetize non-core assets as part of our broader turnaround efforts. The cash proceeds will allow us to pay down a significant portion of our debt and also be used for general corporate purposes.'

Fred's was advised on this transaction by Covington Associates and by Bass Berry & Sims.

About Fred's Inc.
Tracing its history back to an original store in Coldwater, Mississippi, opened in 1947, today Fred's, Inc. operates approximately 600 general merchandise and pharmacy stores, including 12 franchised locations. With unique store formats and strategies that combine the best elements of a value-focused retailer with a healthcare-focused drug store, Fred's stores offer frequently purchased items that address the everyday needs of its customers. This includes nationally recognized brands, proprietary Fred's label products, and a full range of value-priced selections. For more information about the Company, visit Fred's website at www.fredsinc.com. FRED - EntrustRx Closing - FINAL

Attachments

  • Original document
  • Permalink

Disclaimer

Fred's Inc. published this content on 04 June 2018 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 04 June 2018 20:52:02 UTC